Skip to main content
AMRZ
NYSE Manufacturing

Amrize lifts FY revenue target after 8.6% Q2 top-line gain, but trims EBITDA view on cost inflation

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Building Materials Stocks · Materials
Sentiment info
Neutral
Importance info
8
Price
$50.59
Mkt Cap
$28.352B
52W Low
$44.12
52W High
$65.94
52W Position info
15% above low
Off High info
23% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

AMRZ is trading near its 52-week low of $44.12 (15% above the low).

Summary

Amrize posted Q2 revenue of $3.49 billion (+8.6%) and raised its full-year revenue forecast, but lowered adjusted EBITDA guidance on oil-driven cost inflation. Prior financials were also revised for an immaterial deferred revenue error.


Key Events · Earnings and Guidance · AMRZ

  • Q2 Revenue and Earnings Beat

    Revenue rose 8.6% to $3.49 billion on strong volume and pricing; net income increased 14.4% to $476 million, or $0.86 per diluted share.

  • FY Revenue Guidance Raised, EBITDA Trimmed

    Full-year revenue guidance raised to $12.5–$12.7 billion, but adjusted EBITDA guidance lowered to $3.1–$3.2 billion due to oil-price-driven cost inflation.

  • Prior Period Financials Revised

    The company revised prior financial statements to correct an immaterial $78 million understatement of deferred revenue related to extended warranties, with no material impact on any previously issued statements.

  • $502M Returned to Shareholders

    Amrize returned $502 million in Q2 through $197 million in share repurchases and $305 million in dividends, including a special dividend and the first quarterly dividend.


Analysis · AMRZ · Manufacturing

A strong second quarter saw revenue climb 8.6% and net income advance 14.4%, fueled by mega-project demand and favorable pricing. Full-year revenue guidance was raised to $12.5–$12.7 billion, yet the adjusted EBITDA outlook was pared to $3.1–$3.2 billion as oil-driven cost inflation bites. Separately, prior-period financials were revised to correct an immaterial $78 million understatement of deferred revenue — a notable accounting fix, not a restatement. With $502 million returned to shareholders and the July acquisition of Rapid Redi-Mix, the quarter highlights both operational momentum and margin headwinds.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AMRZ was trading at $50.59 on NYSE in the Manufacturing sector, with a market capitalization of approximately $28.4B. The 52-week trading range was $44.12 to $65.94. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AMRZ - Latest Insights

AMRZ
Oct 29, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $41.61
Real-time Price: $39.88 info
Change: -$1.73 (-4%) info
Market Cap: $21.882B info
AMRZ
Oct 28, 2026, 8:18 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $37.64
Real-time Price: $39.88 info
Change: +$2.24 (+6%) info
Market Cap: $21.882B info
AMRZ
Oct 28, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $38.30
Real-time Price: $39.88 info
Change: +$1.58 (+4%) info
Market Cap: $21.882B info
AMRZ
Oct 28, 2026, 4:15 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $38.32
Real-time Price: $39.88 info
Change: +$1.56 (+4%) info
Market Cap: $21.882B info
AMRZ
Aug 10, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $46.29
Real-time Price: $39.88 info
Change: -$6.41 (-14%) info
Market Cap: $21.882B info